Shareholders Equity: The sum of preferred and common equity items.
Aprea Therapeutics, Inc. (APRE) had Shareholders Equity of $15.55M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.16M |
|
$-3.93M |
|
-- |
|
$0.16M |
|
$4.25M |
|
$-4.09M |
|
$0.15M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$-4.09M |
|
$-4.08M |
|
5.99M |
|
5.99M |
|
$-0.66 |
|
$-0.66 |
|
| Balance Sheet Financials | |
$19.83M |
|
$0.08M |
|
$0.39M |
|
$20.22M |
|
$3.36M |
|
-- |
|
$1.31M |
|
$4.67M |
|
$15.55M |
|
$15.55M |
|
|
Shareholders Equity |
$15.55M |
5.51M |
|
| Cash Flow Statement Financials | |
$-3.63M |
|
-- |
|
$0.06M |
|
$22.89M |
|
$19.32M |
|
$-3.57M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2514.78% |
|
-2514.78% |
|
-- |
|
-2420.65% |
|
-2420.65% |
|
$-3.63M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-25.29% |
|
-25.29% |
|
-19.45% |
|
-25.29% |
|
$2.82 |
|
$-0.61 |
|
$-0.61 |
|